Study on tumour cell-derived hybrid exosomes as dasatinib nanocarriers for pancreatic cancer therapy
Volume 51, Issue 1, December 2023, Page 532-546 .
Source: Artificial Cells, Blood Substitutes, and Biotechnology - Category: Biotechnology Authors: Xiaofei ZhouYuetang ZhuangXiaohong LiuYaowen GuJunting WangYuchen ShiLi ZhangRui LiYelin ZhaoHebing ChenJiao LiHongjuan YaoLiang Lia Key Laboratory of Antibiotic Bioengineering of National Health and Family Planning Commission (NHFPC), Institute of Medici Source Type: research
More News: Biotechnology | Cancer | Cancer & Oncology | Cancer Therapy | Laboratory Medicine | Nanotechnology | Pancreas | Pancreatic Cancer | Study